45 related articles for article (PubMed ID: 28911810)
1. New Way to Study Pulmonary Hypertension in HFpEF.
Dai Z; Thorp EB
Circ Res; 2023 Nov; 133(11):899-901. PubMed ID: 37943948
[No Abstract] [Full Text] [Related]
2. Inflammation and Cardiorespiratory Fitness in HFpEF: A Decade of Progress.
Carbone S; Abbate A
JACC Heart Fail; 2024 Jul; 12(7):1270-1273. PubMed ID: 38960521
[No Abstract] [Full Text] [Related]
3. Assessing the clinical utility of the HFpEF nomogram: A call for broader validation.
Albulushi A
Int J Cardiol; 2024 Jul; 406():132038. PubMed ID: 38614363
[No Abstract] [Full Text] [Related]
4. Reply to "Assessing the clinical utility of the HFpEF nomogram: A call for broader validation".
Hua L
Int J Cardiol; 2024 Sep; 410():132214. PubMed ID: 38815670
[No Abstract] [Full Text] [Related]
5. Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.
Naeije R; Gerges M; Vachiery JL; Caravita S; Gerges C; Lang IM
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912263
[TBL] [Abstract][Full Text] [Related]
6. Cardiopulmonary Exercise Testing: What Is its Value?
Guazzi M; Bandera F; Ozemek C; Systrom D; Arena R
J Am Coll Cardiol; 2017 Sep; 70(13):1618-1636. PubMed ID: 28935040
[TBL] [Abstract][Full Text] [Related]
7. What We Talk About When We Talk About the Wedge Pressure.
Houston BA; Tedford RJ
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912264
[No Abstract] [Full Text] [Related]
8. Exercise training in patients with pulmonary and systemic hypertension: A unique therapy for two different diseases.
Leggio M; Fusco A; Limongelli G; Sgorbini L
Eur J Intern Med; 2018 Jan; 47():17-24. PubMed ID: 28911936
[TBL] [Abstract][Full Text] [Related]
9. Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology.
Corrà U; Agostoni PG; Anker SD; Coats AJS; Crespo Leiro MG; de Boer RA; Harjola VP; Hill L; Lainscak M; Lund LH; Metra M; Ponikowski P; Riley J; Seferović PM; Piepoli MF
Eur J Heart Fail; 2018 Jan; 20(1):3-15. PubMed ID: 28925073
[TBL] [Abstract][Full Text] [Related]
10. Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA; Simonneau G; D'Armini AM; Fedullo P; Howard LS; Jaïs X; Jenkins DP; Jing ZC; Madani MM; Martin N; Mayer E; Papadakis K; Richard D; Kim NH;
Lancet Respir Med; 2017 Oct; 5(10):785-794. PubMed ID: 28919201
[TBL] [Abstract][Full Text] [Related]
11. Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension.
Badagliacca R; Raina A; Ghio S; D'Alto M; Confalonieri M; Correale M; Corda M; Paciocco G; Lombardi C; Mulè M; Poscia R; Scelsi L; Argiento P; Sciomer S; Benza RL; Vizza CD
J Heart Lung Transplant; 2018 Mar; 37(3):365-375. PubMed ID: 28912026
[TBL] [Abstract][Full Text] [Related]
12. Cardiopulmonary exercise testing and echocardiographic exam: an useful interaction.
Santoro C; Sorrentino R; Esposito R; Lembo M; Capone V; Rozza F; Romano M; Trimarco B; Galderisi M
Cardiovasc Ultrasound; 2019 Dec; 17(1):29. PubMed ID: 31796047
[TBL] [Abstract][Full Text] [Related]
13. The V˙E/V˙co2 Slope During Maximal Treadmill Cardiopulmonary Exercise Testing: REFERENCE STANDARDS FROM FRIEND (FITNESS REGISTRY AND THE IMPORTANCE OF EXERCISE: A NATIONAL DATABASE).
Arena R; Myers J; Harber M; Phillips SA; Severin R; Ozemek C; Peterman JE; Kaminsky LA
J Cardiopulm Rehabil Prev; 2021 May; 41(3):194-198. PubMed ID: 33470730
[TBL] [Abstract][Full Text] [Related]
14. Effect of Smartphone-Based Telemonitored Exercise Rehabilitation among Patients with Coronary Heart Disease.
Song Y; Ren C; Liu P; Tao L; Zhao W; Gao W
J Cardiovasc Transl Res; 2020 Aug; 13(4):659-667. PubMed ID: 31820334
[TBL] [Abstract][Full Text] [Related]
15. Exercise VE/VCO2 Slope: An Endurance Marker of Prognosis Also in Patients with HFpEF and Pulmonary Hypertension, at Least!
Guazzi M
J Card Fail; 2017 Nov; 23(11):783-785. PubMed ID: 28911810
[No Abstract] [Full Text] [Related]
16. Clinical and Hemodynamic Correlates and Prognostic Value of VE/VCO
Klaassen SHC; Liu LCY; Hummel YM; Damman K; van der Meer P; Voors AA; Hoendermis ES; van Veldhuisen DJ
J Card Fail; 2017 Nov; 23(11):777-782. PubMed ID: 28736291
[TBL] [Abstract][Full Text] [Related]
17. Physiological dead space and arterial carbon dioxide contributions to exercise ventilatory inefficiency in patients with reduced or preserved ejection fraction heart failure.
Van Iterson EH; Johnson BD; Borlaug BA; Olson TP
Eur J Heart Fail; 2017 Dec; 19(12):1675-1685. PubMed ID: 28990307
[TBL] [Abstract][Full Text] [Related]
18. VE/VCO2 slope in older heart failure patients with normal versus reduced ejection fraction compared with age-matched healthy controls.
Moore B; Brubaker PH; Stewart KP; Kitzman DW
J Card Fail; 2007 May; 13(4):259-62. PubMed ID: 17517344
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week.
Guazzi M; Ghio S; Adir Y
J Am Coll Cardiol; 2020 Sep; 76(9):1102-1111. PubMed ID: 32854845
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
